Literature DB >> 17593319

Is the Ability index superior to the NYHA classification for assessing heart failure?: comparison of two classification scales in adolescents and adults with operated congenital heart defects.

Kambiz Norozi1, Armin Wessel, Reiner Buchhorn, Valentin Alpers, Jan O Arnhold, Monika Zoege, Siegfried Geyer.   

Abstract

BACKGROUND: Heart failure (HF) is a major problem in the long-term follow-up of adolescents and adults with congenital heart disease (ACHD) after cardiac surgery. The functional status of ACHD may be assessed in terms of the NYHA classification or the Ability index (ABILITY).
OBJECTIVE: The purpose of our study was to examine which of the two classification systems is more closely related to objectively defined HF.
METHODS: NT-pro brain natriuretic peptide (N-BNP) and maximal oxygen uptake (VO(2max)) were measured in 360 consecutive ACHD patients. HF was defined as an elevated N-BNP level > or =100 pg/ml combined with a reduced VO(2max) < or =25 ml/kg/min.
RESULTS: There were no significant differences between the NYHA and ABILITY in grading HF in these patients. In both classifications, the risk of HF increases continuously over the classes and grades from odds ratio (OR) 1 in NYHA I/ABILITY 1 to an OR=3.4 in NYHA II/ ABILITY 2 up to 11.6 or 5.4 (ns) in NYHA III/ABILITY 3. Thus in the highest scores HF is found in 70-77% of the patients. The fact that in NYHA class I and ABILITY grade 1, 15% and 19% of the patients exhibited HF according to the measured indices underscores the discrepancy between subjective and objective assessment of the individual patients condition.
CONCLUSION: The NYHA classification and the Ability index take different approaches to the patients with congenital heart defects but are equally suitable for the judgement of HF in post surgical ACHD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593319     DOI: 10.1007/s00392-007-0530-z

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  14 in total

1.  No difference in N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations between endurance athletes with athlete's heart and healthy untrained controls.

Authors:  J Scharhag; A Urhausen; M Herrmann; G Schneider; B Kramann; W Herrmann; W Kindermann
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

2.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

Authors:  Karl Swedberg; John Cleland; Henry Dargie; Helmut Drexler; Ferenc Follath; Michel Komajda; Luigi Tavazzi; Otto A Smiseth; Antonello Gavazzi; Axel Haverich; Arno Hoes; Tiny Jaarsma; Jerzy Korewicki; Samuel Lévy; Cecilia Linde; José-Luis Lopez-Sendon; Markku S Nieminen; Luc Piérard; Willem J Remme
Journal:  Eur Heart J       Date:  2005-05-18       Impact factor: 29.983

3.  Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery.

Authors:  Kambiz Norozi; Armin Wessel; Valentin Alpers; Jan Ole Arnhold; Siegfried Geyer; Monika Zoege; Reiner Buchhorn
Journal:  Am J Cardiol       Date:  2006-03-03       Impact factor: 2.778

4.  Is the severity of congenital heart disease associated with the quality of life and perceived health of adult patients?

Authors:  P Moons; K Van Deyk; S De Geest; M Gewillig; W Budts
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

5.  Outcome of the unoperated adult who presents with congenitally corrected transposition of the great arteries.

Authors:  Luc M Beauchesne; Carole A Warnes; Heidi M Connolly; Naser M Ammash; A Jamil Tajik; Gordon K Danielson
Journal:  J Am Coll Cardiol       Date:  2002-07-17       Impact factor: 24.094

6.  Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study.

Authors:  Gysèle S Bleumink; Anneke M Knetsch; Miriam C J M Sturkenboom; Sabine M J M Straus; Albert Hofman; Jaap W Deckers; Jacqueline C M Witteman; Bruno H Ch Stricker
Journal:  Eur Heart J       Date:  2004-09       Impact factor: 29.983

7.  Tricuspid atresia in adolescents and adults: current state and late complications.

Authors:  C A Warnes; J Somerville
Journal:  Br Heart J       Date:  1986-12

8.  Long-term outcome after the mustard repair for simple transposition of the great arteries. 28-year follow-up.

Authors:  N J Wilson; P M Clarkson; B G Barratt-Boyes; A L Calder; R M Whitlock; R N Easthope; J M Neutze
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094

9.  Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.

Authors:  Thomas Mueller; Alfons Gegenhuber; Werner Poelz; Meinhard Haltmayer
Journal:  Clin Chim Acta       Date:  2004-03       Impact factor: 3.786

10.  Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing.

Authors:  Jens Peter Goetze; Jens Kastrup; Frants Pedersen; Jens F Rehfeld
Journal:  Clin Chem       Date:  2002-07       Impact factor: 8.327

View more
  8 in total

1.  Anomalous origin of the left coronary artery from the pulmonary artery: mid-term results after surgical correction.

Authors:  Wlodzimierz Kuroczynski; Christoph Kampmann; Nalan Kayhan; Markus Heinemann; Diethard Pruefer; Christian-Friedrich Vahl
Journal:  Clin Res Cardiol       Date:  2008-02-22       Impact factor: 5.460

2.  The initial slope of the VCO2/VO2-curve (s1) in cardiopulmonary exercise testing is a strong and independent predictor of outcome in patients with previous myocardial infarction.

Authors:  Joerg Honold; Lenka Geiger; Birgit Assmus; Ulrich Fischer-Rasokat; Volker Schaechinger; Andreas M Zeiher; Ioakim Spyridopoulos
Journal:  Clin Res Cardiol       Date:  2008-08-11       Impact factor: 5.460

3.  A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomal-dominant inherited congenital heart disease.

Authors:  S Pabst; B Wollnik; E Rohmann; Y Hintz; K Glänzer; H Vetter; G Nickenig; C Grohé
Journal:  Clin Res Cardiol       Date:  2007-09-25       Impact factor: 5.460

4.  Replacement of valved right ventricular to pulmonary artery conduits: an observational study with focus on right ventricular geometry.

Authors:  Tsvetomir Loukanov; Christian Sebening; Wolfgang Springer; Markus Khalil; Herbert E Ulmer; Siegfried Hagl; Matthias Karck; Matthias Gorenflo
Journal:  Clin Res Cardiol       Date:  2007-11-28       Impact factor: 5.460

Review 5.  Commonalities and differences in correlates of depressive symptoms in men and women with heart failure.

Authors:  Jo-Ann Eastwood; Debra K Moser; Barbara J Riegel; Nancy M Albert; Susan Pressler; Misook L Chung; Sandra Dunbar; Jia-Rong Wu; Terry A Lennie
Journal:  Eur J Cardiovasc Nurs       Date:  2012-03-13       Impact factor: 3.908

6.  Angiopoietin-2 in adults with congenital heart disease and heart failure.

Authors:  Alexander Lukasz; Gernot Beutel; Philipp Kümpers; Agnieszka Denecke; Mechthild Westhoff-Bleck; Bernhard Schieffer; Johann Bauersachs; Jan T Kielstein; Oktay Tutarel
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

7.  Asymmetrical dimethylarginine--more sensitive than NT-proBNP to diagnose heart failure in adults with congenital heart disease.

Authors:  Oktay Tutarel; Agnieszka Denecke; Stefanie M Bode-Böger; Jens Martens-Lobenhoffer; Svjetlana Lovric; Johann Bauersachs; Bernhard Schieffer; Mechthild Westhoff-Bleck; Jan T Kielstein
Journal:  PLoS One       Date:  2012-03-21       Impact factor: 3.240

Review 8.  Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases.

Authors:  Patryk Leczycki; Maciej Banach; Marek Maciejewski; Agata Bielecka-Dabrowa
Journal:  Front Cardiovasc Med       Date:  2022-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.